Elevated IL-8, TNF-α, and MCP-I in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival

Sharma, J.Gray, K.Harshman, L.Evan, C.Nakabayashi, M.Fichorova, R.Rider, J.Mucci, L.Kantoff, P.Sweeney, C.2015-08-112015-08-112014Prostate, 2014; 74(8):820-8280270-41371097-0045http://hdl.handle.net/2440/93474Abstract not availableen© 2014 Wiley Periodicals, Inc.elevated IL-8; TNF-α and MCP-1; inflammation; prostate cancerElevated IL-8, TNF-α, and MCP-I in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survivalElevated IL-8, TNF-alpha, and MCP-I in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survivalJournal article003002918810.1002/pros.227880003348938000032-s2.0-84899585828186410Sweeney, C. [0000-0002-0398-6018]